CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
AstraZeneca PLC (AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company. Focusing on the discovery and development of prescription medicines, the company operates a portfolio of products designed to treat various diseases, including autoimmune, respiratory, inflammation, cardiovascular, oncology and many more. Primarily listed on the London Stock Exchange (LSE), AstraZeneca is included into the FTSE 100 index. The innovative medicines created by this global, science-led company help millions of people around the globe.
The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.
14:43, 2 February 2024
Read our reviews to find out more about us
Read the feedback from our clients, whatever their experience level.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.